These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12122958)

  • 1. Safety of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children.
    Piedra PA
    Semin Pediatr Infect Dis; 2002 Apr; 13(2):90-6. PubMed ID: 12122958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children.
    Piedra PA; Yan L; Kotloff K; Zangwill K; Bernstein DI; King J; Treanor J; Munoz F; Wolff M; Cho I; Mendelman PM; Cordova J; Belshe RB
    Pediatrics; 2002 Oct; 110(4):662-72. PubMed ID: 12359778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia.
    Tam JS; Capeding MR; Lum LC; Chotpitayasunondh T; Jiang Z; Huang LM; Lee BW; Qian Y; Samakoses R; Lolekha S; Rajamohanan KP; Narayanan SN; Kirubakaran C; Rappaport R; Razmpour A; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2007 Jul; 26(7):619-28. PubMed ID: 17596805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities.
    Nolan T; Lee MS; Cordova JM; Cho I; Walker RE; August MJ; Larson S; Coelingh KL; Mendelman PM
    Vaccine; 2003 Mar; 21(11-12):1224-31. PubMed ID: 12559802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
    Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
    Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children.
    Bernstein DI; Yan L; Treanor J; Mendelman PM; Belshe R;
    Pediatr Infect Dis J; 2003 Jan; 22(1):28-34. PubMed ID: 12544405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
    Belshe RB; Gruber WC
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1947-51. PubMed ID: 11779396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents.
    Bergen R; Black S; Shinefield H; Lewis E; Ray P; Hansen J; Walker R; Hessel C; Cordova J; Mendelman PM
    Pediatr Infect Dis J; 2004 Feb; 23(2):138-44. PubMed ID: 14872180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative immunogenicities of frozen and refrigerated formulations of live attenuated influenza vaccine in healthy subjects.
    Block SL; Reisinger KS; Hultquist M; Walker RE;
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4001-8. PubMed ID: 17724151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses.
    Treanor JJ; Kotloff K; Betts RF; Belshe R; Newman F; Iacuzio D; Wittes J; Bryant M
    Vaccine; 1999 Dec; 18(9-10):899-906. PubMed ID: 10580204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children.
    Gaglani MJ; Piedra PA; Herschler GB; Griffith ME; Kozinetz CA; Riggs MW; Fewlass C; Halloran ME; Longini IM; Glezen WP
    Arch Pediatr Adolesc Med; 2004 Jan; 158(1):65-73. PubMed ID: 14706961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children.
    King JC; Lagos R; Bernstein DI; Piedra PA; Kotloff K; Bryant M; Cho I; Belshe RB
    J Infect Dis; 1998 May; 177(5):1394-7. PubMed ID: 9593032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children.
    Boyce TG; Gruber WC; Coleman-Dockery SD; Sannella EC; Reed GW; Wolff M; Wright PF
    Vaccine; 1999 Aug; 18(1-2):82-8. PubMed ID: 10501238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of influenza vaccine for healthy children in the US.
    Block SL
    Paediatr Drugs; 2004; 6(4):199-209. PubMed ID: 15339199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of live influenza vaccines in children.
    Gruber WC
    Vaccine; 2002 May; 20 Suppl 2():S66-73. PubMed ID: 12110263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years.
    Belshe RB; Nichol KL; Black SB; Shinefield H; Cordova J; Walker R; Hessel C; Cho I; Mendelman PM
    Clin Infect Dis; 2004 Oct; 39(7):920-7. PubMed ID: 15472840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.
    Vesikari T; Karvonen A; Smith HM; Dunning A; Razmpour A; Saville MK; Gruber WC; Forrest BD
    Pediatrics; 2008 Mar; 121(3):e568-73. PubMed ID: 18299305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.